Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2021, Vol. 26 ›› Issue (9): 978-985.doi: 10.12092/j.issn.1009-2501.2021.09.002

Previous Articles     Next Articles

Tangshen formula improves cholesterol uptake and efflux of macrophages induced by high lipid via activating PGC-1α/LXR/ABCA1 pathway

XU Ke 1, GAO Junwei 1, LIU Peng 2, SHEN Zhengri 2, JIA Hui 2, WU Chenguang 1, TIAN Feng 1, WANG Lifan 1, LI Ping 3   

  1. 1 Heilongjiang Academy of Chinese Medicine Sciences, Harbin 150000, Heilongjiang, China; 2 Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital, Beijing 101300, China; 3 Beijing Key Lab Immune-mediated Inflammatory Diseases, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China
  • Received:2021-03-16 Revised:2021-05-23 Online:2021-09-26 Published:2021-09-30

Abstract: AIM: To observe the effects of Tangshen formula (TSF) treatment on lipid efflux and uptake in sodium palmitate (PA) induced RAW264.7 macrophages.  METHODS: After 200 μmol/L PA induced RAW264.7 macrophages, TSF and PGC-1α-siRNA were given to intervene respectively. The lipid content in the cells was detected by ELISA kit; intracellular lipid droplet deposition was detected by BODIPY 493/503 and Filipin staining. Western blot and Real-time PCR were used to detect the expression of PGC-1α, LXR, ABCA1 and CD36. RESULTS:  TSF diminished the levels of TC, TG and intracellular lipid droplet deposition in PA-induced RAW264.7 macrophages. Western blot and Real-time PCR analysis showed that TSF could up-regulate the expression of PGC-1α, LXR, ABCA1 and down-regulate the expression of CD36. Furthermore, silencing PCG-1α by SiRNA significantly suppressed the effects of upregulating the expression of PGC-1α, LXR and ABCA1, and downregulating the CD36 expression with TSF treatment. CONCLUSION: TSF may extenuate intracellular lipid droplet deposition in macrophages by upregulating cholesterol efflux through activating the PGC-1α/LXR/ABCA1 pathway and inhibiting lipid uptake through down-regulateing the expression of CD36.

Key words: Tangshen formula, hyperlipidemia, PGC-1α/LXR/ABCA1 pathway, CD36

CLC Number: